PURPOSE: Assessing the efficacy of treatment modalities for diabetic retinopathy (DR) from the patient's perspective is restricted due to a lack of a comprehensive patient-reported outcome measure. We are developing a DR-specific quality of life (QoL) item bank, and we report here on the qualitative results from the first phase of this project. METHODS: Eight focus groups and 18 semi-structured interviews were conducted with 57 patients with DR. The sessions were transcribed verbatim and iteratively analysed using the constant comparative method and NVIVO software. RESULTS: Participants had a median age of 58 years (range 27-83 years). Twenty-seven (47%) participants had proliferative DR in the better eye, and 14 (25%) had clinically significant macular oedema. Nine QoL domains were identified, namely visual symptoms, ocular surface symptoms, vision-related activity limitation, mobility, emotional well-being, health concerns, convenience, social, and economic. Participants described many vision-related activity limitations, particularly under challenging lighting conditions; however, socioemotional issues were equally important. Participants felt frustrated due to their visual restrictions, concerned about further vision loss and had difficulty coping with this uncertainty. Restrictions on driving were pervasive, affecting transport, social life, relationships, responsibilities, work and independence. CONCLUSIONS: Patients with DR experience many socioemotional issues in addition to vision-related activity limitations. Data from this study will be used to generate data for a DR-specific QoL item bank.
PURPOSE: Assessing the efficacy of treatment modalities for diabetic retinopathy (DR) from the patient's perspective is restricted due to a lack of a comprehensive patient-reported outcome measure. We are developing a DR-specific quality of life (QoL) item bank, and we report here on the qualitative results from the first phase of this project. METHODS: Eight focus groups and 18 semi-structured interviews were conducted with 57 patients with DR. The sessions were transcribed verbatim and iteratively analysed using the constant comparative method and NVIVO software. RESULTS:Participants had a median age of 58 years (range 27-83 years). Twenty-seven (47%) participants had proliferative DR in the better eye, and 14 (25%) had clinically significant macular oedema. Nine QoL domains were identified, namely visual symptoms, ocular surface symptoms, vision-related activity limitation, mobility, emotional well-being, health concerns, convenience, social, and economic. Participants described many vision-related activity limitations, particularly under challenging lighting conditions; however, socioemotional issues were equally important. Participants felt frustrated due to their visual restrictions, concerned about further vision loss and had difficulty coping with this uncertainty. Restrictions on driving were pervasive, affecting transport, social life, relationships, responsibilities, work and independence. CONCLUSIONS:Patients with DR experience many socioemotional issues in addition to vision-related activity limitations. Data from this study will be used to generate data for a DR-specific QoL item bank.
Authors: Michael Cusick; John Paul SanGiovanni; Emily Y Chew; Karl G Csaky; Katherine Hall-Shimel; George F Reed; Rafael C Caruso; Frederick L Ferris Journal: Am J Ophthalmol Date: 2005-06 Impact factor: 5.258
Authors: Ecosse L Lamoureux; Julie F Pallant; Konrad Pesudovs; Gwyn Rees; Jennifer B Hassell; Jill E Keeffe Journal: Invest Ophthalmol Vis Sci Date: 2007-03 Impact factor: 4.799
Authors: Ecosse L Lamoureux; John G Ferraro; Julie F Pallant; Konrad Pesudovs; Gwyn Rees; Jill E Keeffe Journal: Optom Vis Sci Date: 2007-08 Impact factor: 1.973
Authors: Derek LeRoith; Geert Jan Biessels; Susan S Braithwaite; Felipe F Casanueva; Boris Draznin; Jeffrey B Halter; Irl B Hirsch; Marie E McDonnell; Mark E Molitch; M Hassan Murad; Alan J Sinclair Journal: J Clin Endocrinol Metab Date: 2019-05-01 Impact factor: 5.958
Authors: Eva K Fenwick; Konrad Pesudovs; Jyoti Khadka; Gwyn Rees; Tien Y Wong; Ecosse L Lamoureux Journal: Qual Life Res Date: 2012-11-08 Impact factor: 4.147
Authors: Krystal Khoo; Ryan E K Man; Gwyn Rees; Preeti Gupta; Ecosse L Lamoureux; Eva K Fenwick Journal: Qual Life Res Date: 2019-03-16 Impact factor: 4.147
Authors: Eva K Fenwick; Ester P X Lee; Ryan E K Man; Kam Chun Ho; Raymond P Najjar; Dan Milea; Kelvin Y C Teo; Anna C S Tan; Shu Yen Lee; Ian Yew San Yeo; Gavin S W Tan; Ranjana Mathur; Tien Yin Wong; Chui Ming Gemmy Cheung; Ecosse L Lamoureux Journal: Qual Life Res Date: 2021-09-25 Impact factor: 4.147
Authors: Nuria Alcubierre; Esther Rubinat; Alicia Traveset; Montserrat Martinez-Alonso; Marta Hernandez; Carmen Jurjo; Didac Mauricio Journal: Health Qual Life Outcomes Date: 2014-08-20 Impact factor: 3.186